© Springer International Publishing Switzerland 2015Gunnar Baatrup (ed.)Multidisciplinary Treatment of Colorectal Cancer10.1007/978-3-319-06142-9_23 23. Staging of Colorectal Cancer (Including Staging After Neoadjuvant Therapy) Iris D. Nagtegaal1 (1) Department of Pathology, Radboud University Nijmegen Medical Center, Geert Grooteplein…
© Springer International Publishing Switzerland 2015Gunnar Baatrup (ed.)Multidisciplinary Treatment of Colorectal Cancer10.1007/978-3-319-06142-9_20 20. Introduction to the Pathology of Colorectal Cancer Iris D. Nagtegaal1 (1) Department of Pathology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands …
© Springer International Publishing Switzerland 2015Gunnar Baatrup (ed.)Multidisciplinary Treatment of Colorectal Cancer10.1007/978-3-319-06142-9_10 10. Locally Advanced and Recurrent Cancer T. Wiggers1 and K. Havenga1 (1) Department of Surgery, University Medical Center Groningen, 30 001, Groningen, 9700 RB,…
© Springer International Publishing Switzerland 2015Gunnar Baatrup (ed.)Multidisciplinary Treatment of Colorectal Cancer10.1007/978-3-319-06142-9_17 17. Introduction: Preoperative Staging by Imaging Regina G. H. Beets-Tan1 (1) Department of Radiology, Maastricht University Medical Center, Maastricht, The Netherlands Regina G. H. Beets-Tan Email:…
21. Quirke P, Dixon MF, Durdey P, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet. 1986;1:996–8.CrossRef 22. Heald RJ, Husband EM, Ryall RDH. The mesorectum…
© Springer International Publishing Switzerland 2015Gunnar Baatrup (ed.)Multidisciplinary Treatment of Colorectal Cancer10.1007/978-3-319-06142-9_1 1. Organizing the Multidisciplinary Team Gunnar Baatrup1, 2 (1) Institute of Regional Health Science, University of Southern Denmark, Svendborg, Denmark (2) Department of…
Fig. 13.1 The metabolism of fluoropyrimidines (Adapted from Longley et al. [3]) For many years, the best administration schedule for FU has been debated, and many efforts have been made…
Authors No. of pts RT dose Gy/fractions/ days T2 Chemo Procedure cCR No failing Local failure Habr-Gama et al. [24] 118 50.4/28/38 Yes Bolus FUFA No surgery 32 % 8/30…
Low-risk ERC High-risk ERC Absolute factors Morphology Polypoid Ulcerated Sessile Flat raised Tumour grade G1–G2 G3–G4/signet ring Depth of invasion Haggitt 1–3 Haggitt 4 pT1sm1 pT1sm2–3 Lympho-vascular invasion No…
Fig. 6.1 Tumour cell migration within a vein (V1) and tumour cell invasion in a lymphatic vessel (L1) Independent from this, it was documented that the proportion of ‘high-risk’ tumours…
